Pure Global AI
Disease / condition

Covid19 clinical trials

Free access to 950 studies10+ countriesUpdated daily333 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
950
Total trials
10+
Countries
10+
Sponsors
333
Recruiting
By phase
N/A561
Phase 2132
Phase 392
Phase 150
Phase 2/339
By status
Recruiting333
Completed289
Not yet recruit...210
Withdrawn31
Enrolling by in...30
Top countries
United States of America207
France78
Egypt51
Turkey41
Italy40
Top sponsors
Assiut University25
Sorrento Therapeut...12
Assistance Publiqu...11
Stanford Universit...9
University of Penn...9
Recent trials
Latest clinical trials for Covid19
Model to Predict Coinfection in Elderly Patients With COVID-19
Xiangya Hospital of Central So... · China
NCT06321367Completed
COVID-19 Personal Protective Equipment for Vaccinated Health Workers and Convalescents
University Medical Centre Ljub... · Slovenia
NCT06158724Withdrawn
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)
Susanna Naggie, MD · United States of America
NCT06042855Recruiting
Phase
Phase 3
KAND567 Versus Placebo in Subjects Hospitalized With COVID-19
Kancera AB · Denmark,Sweden
NCT06012565Terminated
Phase
Phase 2
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)
Susanna Naggie, MD · United States of America
NCT05894564Completed
Phase
Phase 3
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)
Susanna Naggie, MD · United States of America
NCT05894538Completed
Phase
Phase 3
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)
Susanna Naggie, MD · United States of America
NCT05894577Not yet recr...
Phase
Phase 3
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)
Susanna Naggie, MD · United States of America
NCT05890586Completed
Phase
Phase 3
Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes
Stanford University · United States of America
NCT05777720Enrolling by...
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)
Susanna Naggie, MD · United States of America
NCT05736861Completed
Phase
Phase 3
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)
Susanna Naggie, MD · United States of America
NCT05736874Completed
Phase
Phase 3
Analysis of Breathing Pattern Post COVID-19
Shirley Lima Campos · Brazil
NCT05659615Recruiting
COVID-19 Citizen Science Expansion Project
University of California, San ... · United States of America
NCT05548803Enrolling by...
EFFECTS OF INSPIRATORY MUSCLE TRAINING IN POST-COVID-19 PATIENTS
University Vila Velha · Brazil
NCT05493410Completed
Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)
Vir Biotechnology, Inc. · United States of America
NCT05280717Recruiting
Phase
Phase 1
To Evaluate Safety & Immunogenicity of DelNS1-2019-nCoV-RBD-OPT1 for COVID-19 in Healthy Adults Received 2 Doses of BNT162b2
The University of Hong Kong · China
NCT05200741Recruiting
Phase
Phase 2
Face Masks to Reduce SARS-CoV-2 Infections (COVID-19) in Bangladesh
Yale University · Bangladesh
NCT05197725Withdrawn
Sotrovimab Expanded Access Treatment Protocol (COVID-19)
Vir Biotechnology, Inc. · United States of America
NCT05235347No longer av...
Conversations You Want About Corona Virus Disease (COVID-19)
Wake Forest University Health ... · United States of America
NCT05191420Recruiting
Novaferon in Non-hospitalized Adult Patients With Mild COVID-19
Genova Inc. · Japan
NCT05172037Recruiting
Phase
Phase 3
About this profile

Access comprehensive clinical trial information for Covid19 through Pure Global AI's free database. This collection includes 950 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 333 trials are actively recruiting participants.

Research for Covid19 is being conducted in United States of America, France, Egypt and 7+ other countries. Leading sponsors include Assiut University and Sorrento Therapeutics, Inc.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 950 clinical trials studying Covid19, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Assiut University, Sorrento Therapeutics, Inc., Assistance Publique - Hôpitaux de Paris, among others.